Navigation Links
Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
Date:12/20/2010

ed States, Europe and Asia. J&JPRD is focusing its drug discovery and drug development efforts to address unmet medical needs worldwide in a variety of therapeutic areas including cardiovascular and metabolic diseases, oncology, immunology, central nervous system disorders and virology. More information can be found at http://www.jnjpharmarnd.com.

About Ortho Biotech Oncology Research & Development, Unit of Cougar Biotechnology, Inc.

Ortho Biotech Oncology Research & Development, unit of Cougar Biotechnology, Inc., partners with affiliated units and companies in the Janssen Pharmaceutical Companies of Johnson & Johnson, such as Centocor Ortho Biotech Inc. and J&JPRD, in the research and development of oncology and supportive care treatments. 

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Centocor Ortho Biotech Inc., J&JPRD, Janssen-Cilag International NV and/or Johnson & Johnson. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010.  Copies of this Form 10-
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
2. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
3. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
4. MD+DI, MPMN, and OrthoTec Announce Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices
5. Ascension Orthopedics Implants PyroTITAN™ in France
6. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
7. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
8. Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016
9. Reportlinker Adds Asia-Pacific Orthopedic Devices Market Outlook to 2016
10. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
11. Ascension Orthopedics Announces Implantation of the TITAN™ Modular Total Shoulder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 Auxilium ... specialty biopharmaceutical company, today announced that its Board ... non-binding and conditional proposal from Endo International plc ... and legal advisors, has unanimously determined it is ... its existing merger agreement with QLT Inc. ("QLT") ...
(Date:9/20/2014)... /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in consultation ... Mylan-Nitro Spray 0.4 mg/metered dose due to the product missing ... A missing "dip tube" could pose a ... This defect may lead patients to believe they are receiving ... it. Not receiving nitroglycerin could place them at risk for ...
(Date:9/19/2014)... 19, 2014 A pharmaceutical executive in the ... three issues he wanted the research and consulting firm ... personnel (especially for secondary research) to maximize efficiency and ... increased workload , Automation of market research processes ... , How to implement and manage those automated systems ...
Breaking Medicine Technology:Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... The complex cases performed,during this month,s ... Das, an interventional cardiologist at Presbyterian,Hospital of ... vascular,disease, a looming health concern as the ... heart disease. The country,s obesity epidemic will ...
... Calif., Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ... radiosurgery,announced today that the company is partnering with ... in Houston, Texas to launch a prospective,clinical study ... Patients in the study will be randomly assigned ...
Cached Medicine Technology:Cardiologists Tackle 'Next Frontier' in Cardiovascular Disease 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4
(Date:9/22/2014)... Pain does not need to rule your life ... reader-friendly book designed to guide the individual who suffers with ... book is written to help the reader who is struggling ... regain a pain-free life — a daily “go-to” guide on ... pain has become an epidemic, with over 100 million Americans ...
(Date:9/22/2014)... YORK (September 22, 2014) Montefiore Medical Center, Albert Einstein ... Women,s Hospital have received a $300,000 grant from The ... the impact of health Information Technology (IT) on patient ... electronic orders, an important clinical patient safety issue impacted ... will be the first time IT leaders have data ...
(Date:9/22/2014)... of flavonoid found in hops and beer, has been ... in young mice, but not in older animals. , ... Research by scientists from the Linus Pauling Institute ... It,s another step toward understanding, and ultimately reducing the ... mammalian species, including humans. , Flavonoids are compounds found ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Medical ... for a three-day conference to discuss brain-related diseases ... injury from concussions and neurodegenerative disorders. , ... director affiliated with a Silverado memory care community ... dedicated expertise in memory care, hosts the annual ...
(Date:9/22/2014)... North Carolina at Chapel Hill researchers represents an important ... are experiencing the earliest stages of psychosis. , Psychosis ... severe mental disorders such as schizophrenia. Schizophrenia emerges in ... in every 100 people. In severe cases, the impact ... and the burden on family members can be almost ...
Breaking Medicine News(10 mins):Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:AHRQ grant awarded to study the impact of health IT on patient safety at Montefiore and Einstein and Brigham and Women's Hospital 2Health News:Compound from hops aids cognitive function in young animals 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:Blood test may help determine who is at risk for psychosis 2
... -CTA Acceptance in the Netherlands Triggers Milestone Payment ... Radius Health ("Radius"),announced today that the Dutch regulatory ... RAD1901, Radius, novel,tissue-selective SERM (selective estrogen receptor modulator) ... to begin a Phase I,clinical trial of RAD1901 ...
... Thanks to Nutrition on the Go, an,innovative new program ... more than 1,700 restaurants nationwide is available in,a flash through ... and menu item., Not cell phone savvy? No worries. ... menu item you need help with, then send that info ...
... LANCASTER, Pa., Jan. 30 Members of Highmark,s,FreedomBlue ... care options. Effective immediately, both routine and emergency,medical ... and Lancaster,Regional hospitals., "We,re pleased to partner ... and high-quality health care to people with Medicare ...
... CHESTER, N.J. and SLOUGH, England, Jan. 30 ... the,successful completion of its acquisition of Adams Respiratory ... cash tender offer followed by a,short- form merger ... and into Adams. As a result of this ...
... (OTC Bulletin,Board: NTRZ) announced today that it has filed ... U.S. Securities and Exchange,Commission (SEC). If and when declared ... offer and sell under the universal shelf registration,statement up ... preferred,stock, depositary shares and/or warrants to purchase any of ...
... Jan. 30 EMH Regional Healthcare System has,selected ... increasing bad debt and streamline administration of its ... is a 434-bed, non-profit hospital,system with campuses in ... the,EMH Regional Healthcare System has served the needs ...
Cached Medicine News:Health News:Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 2Health News:Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 3Health News:Ring Up Instant Nutrition Info via Text Message to DIET1 (34381) 2Health News:Heart of Lancaster and Lancaster Regional Join Highmark Blue Shield Medicare Advantage Network 2Health News:Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc. 2Health News:NutraCea Files Universal Shelf Registration Statement 2Health News:EMH Regional Medical Center Selects TransUnion's Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 2Health News:EMH Regional Medical Center Selects TransUnion's Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 3
... 150 watt halogen light ... , ,SOLOS Endoscopy shares ... patient with the highest quality ... research and development of advanced ...
... first for Linvatec! The EnVision Autoclavable ... and proprietary technology to ensure true ... Shockflex prism system gives our customers ... their investment. With an integrated multi-specialty ...
... surgery is founded on superior medical video ... 3-Chip cameras, 1-Chip cameras, Light sources, Couplers ... demanding needs., ,Superior resolution and color ... 3-Chip cameras, and are the benchmark by ...
... System provides easy-to-use features, auto iris, white ... camera head construction is based on Solos ... 1-Chip Camera System, Domestic (GS 9960-NTSC) includes: ... with power cord and video cables , ...
Medicine Products: